Drugmakers' deal making will plow ahead despite antitrust scrutiny, analysts sayMarket Watch • 07/12/23
DICE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of DICE Therapeutics, Inc. - DICEBusiness Wire • 07/11/23
Eli Lilly takeover of DICE Therapeutics ‘makes strategic sense,' says brokerProactive Investors • 06/21/23
DICE THERAPEUTICS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of DICE Therapeutics, Inc. - DICEBusiness Wire • 06/21/23
Eli Lilly's $2.4 Billion Acquisition of Dice Therapeutics: What Investors Need to KnowThe Motley Fool • 06/20/23
Shareholder Alert: Ademi LLP investigates whether DICE Therapeutics, Inc. has obtained a Fair Price in its transaction with Eli Lilly and CompanyPRNewsWire • 06/20/23
Dice Therapeutics Stock Catapults To Record High On $2.4 Billion Eli Lilly BuyoutInvestors Business Daily • 06/20/23
DICE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of DICE Therapeutics, Inc. Is Fair to ShareholdersBusiness Wire • 06/20/23